19.04.2018 RHÖN-KLINIKUM AG  DE0007042301

DGAP-News: RHÖN-KLINIKUM AG: Supervisory Board comments on article in manager magazin


 
DGAP-News: RHÖN-KLINIKUM AG / Key word(s): Statement/Statement RHÖN-KLINIKUM AG: Supervisory Board comments on article in manager magazin 19.04.2018 / 16:22 The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Corporate News Bad Neustadt Neustadt / Saale | 19 April 2018 Supervisory Board of RHÖN-KLINIKUM AG comments on article in manager magazin manager magazin (5/2018 issue) reports as follows in its article "Kranke Kultur" (English: sick culture) published online today and to be published in its print issue tomorrow: "There are not a few within the Group who claim that Münch would like to get rid of his once trusted confidant Holzinger sooner rather than later." Referring to the above article, the chairman of the Supervisory Board Eugen Münch as well as the member of the Supervisory Board Prof. Dr. h. c. Ludwig Georg Braun, both major shareholders of RHÖN-KLINIKUM AG, and Georg Schulze-Ziehaus, deputy chairman of the Supervisory Board and ver.di divisional head for healthcare and social affairs in Hessen (Fachbereichsleiter Gesundheit und Soziales in Hessen), comment as follows: "Current reporting by manager magazine alleging that the replacement of Board of Management chairman Stephan Holzinger was desired or intended is false and totally unfounded." ------------------------------------------------------------------------------------------------- RHÖN‐KLINIKUM AG is one of the largest healthcare providers in Germany. The hospital group offers excellent medical care with a direct link to universities and research institutes. More than 830,000 patients are treated every year at the five group hospitals located in Bad Berka, Bad Neustadt, Frankfurt (Oder), Giessen and Marburg where approx. 16,700 employees work. With the RHÖN campus concept the Company is currently implementing a new and forward-looking project which raises fully comprehensive healthcare in rural areas to a new level of excellence and is geared to the growing needs of patients. www.rhoen-klinikum-ag.com Contact: RHÖN-KLINIKUM AG Corporate Communications T. +49 9771 65-1327 | [email protected] --------------------------------------------------------------------------- 19.04.2018 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: RHÖN-KLINIKUM AG Salzburger Leite 1 97616 Bad Neustadt a.d.Saale Germany Phone: +49 (0)9771 - 65-0 Fax: +49 (0)9771 - 97 467 E-mail: [email protected] Internet: www.rhoen-klinikum-ag.com ISIN: DE0007042301 WKN: 704230 Indices: SDAX Listed: Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Stuttgart, Tradegate Exchange End of News DGAP News Service --------------------------------------------------------------------------- 676675 19.04.2018


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 1.211,08 1.232,91 1.303,90 1.360,16 1.402,01 1.446,09 1.463,98
EBITDA1,2 97,82 125,54 125,33 80,23 101,16 105,65 105,88
EBITDA-Marge3 8,08 10,18 9,61 5,90 7,22 7,31
EBIT1,4 38,70 64,94 56,80 10,60 30,52 36,11 40,40
EBIT-Marge5 3,20 5,27 4,36 0,78 2,18 2,50 2,76
Jahresüberschuss1 36,74 51,19 44,48 2,46 30,23 26,94 40,17
Netto-Marge6 3,03 4,15 3,41 0,18 2,16 1,86 2,74
Cashflow1,7 80,30 49,50 47,30 113,30 97,50 41,30 109,00
Ergebnis je Aktie8 0,53 0,73 0,65 0,02 0,42 0,38 0,58
Dividende8 0,22 0,29 0,00 0,00 0,00 0,15 0,35
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: KPMG

INVESTOR-INFORMATIONEN
©boersengefluester.de
Rhön-Klinikum
WKN Kurs in € Einschätzung Börsenwert in Mio. €
704230 12,800 Halten 857,12
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
21,33 28,47 0,75 21,88
KBV KCV KUV EV/EBITDA
0,68 7,86 0,59 7,50
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,15 0,00 0,00 05.06.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
08.05.2024 08.08.2024 07.11.2024 28.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
16,41% 14,06% 28,00% -3,03%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu RHÖN-KLINIKUM AG  ISIN: DE0007042301 können Sie bei EQS abrufen


Pflegeeinrichtungen , 704230 , RHK , XETR:RHK